BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $128B
1-Year Est. Return 19.59%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Quarter Est. Return
1 Year Est. Return
+19.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$129B
AUM Growth
-$2.36B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,847
New
Increased
Reduced
Closed

Top Buys

1 +$592M
2 +$441M
3 +$428M
4
SOXX icon
iShares Semiconductor ETF
SOXX
+$423M
5
META icon
Meta Platforms (Facebook)
META
+$387M

Top Sells

1 +$892M
2 +$816M
3 +$567M
4
QUAL icon
iShares MSCI USA Quality Factor ETF
QUAL
+$494M
5
IBM icon
IBM
IBM
+$477M

Sector Composition

1 Technology 28.65%
2 Consumer Discretionary 9.73%
3 Financials 9.7%
4 Healthcare 9.67%
5 Communication Services 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEMB icon
3301
iShares JPMorgan EM Corporate Bond ETF
CEMB
$397M
$45.8K ﹤0.01%
1,008
+634
KALV icon
3302
KalVista Pharmaceuticals
KALV
$688M
$45.7K ﹤0.01%
4,041
+1,292
MTSR
3303
DELISTED
Metsera Inc
MTSR
$45.5K ﹤0.01%
1,600
+800
AMCX icon
3304
AMC Networks
AMCX
$340M
$45.5K ﹤0.01%
7,252
-73,889
AVIR icon
3305
Atea Pharmaceuticals
AVIR
$231M
$45.5K ﹤0.01%
12,627
-71,734
PACB icon
3306
Pacific Biosciences
PACB
$486M
$45.2K ﹤0.01%
36,462
-7,359
EDIT icon
3307
Editas Medicine
EDIT
$254M
$44.8K ﹤0.01%
20,381
-25,257
TSSI
3308
TSS Inc
TSSI
$249M
$44.7K ﹤0.01%
+1,552
CCRN icon
3309
Cross Country Healthcare
CCRN
$365M
$44.7K ﹤0.01%
3,424
+1,142
RCMT icon
3310
RCM Technologies
RCMT
$144M
$44.6K ﹤0.01%
1,892
+579
EBF icon
3311
Ennis
EBF
$433M
$44.6K ﹤0.01%
2,456
+890
ACNB icon
3312
ACNB Corp
ACNB
$491M
$44.4K ﹤0.01%
1,036
+374
KIDS icon
3313
OrthoPediatrics
KIDS
$419M
$44.1K ﹤0.01%
2,053
-170
TNGX icon
3314
Tango Therapeutics
TNGX
$1.1B
$44.1K ﹤0.01%
8,609
-38,920
LUXE
3315
LuxExperience B.V.
LUXE
$1.27B
$43.9K ﹤0.01%
5,533
-3,810
IVR icon
3316
Invesco Mortgage Capital
IVR
$540M
$43.9K ﹤0.01%
5,599
+2,548
CIVB icon
3317
Civista Bancshares
CIVB
$423M
$43.9K ﹤0.01%
1,891
-12,516
BTBT icon
3318
Bit Digital
BTBT
$775M
$43.8K ﹤0.01%
19,992
+9,946
CMRE icon
3319
Costamare
CMRE
$1.76B
$43.6K ﹤0.01%
4,788
-60,095
SLP icon
3320
Simulations Plus
SLP
$348M
$43.4K ﹤0.01%
2,485
-40,192
JELD icon
3321
JELD-WEN Holding
JELD
$174M
$43.3K ﹤0.01%
11,051
-20,732
EDAP
3322
EDAP TMS
EDAP
$78.5M
$43.1K ﹤0.01%
26,105
-14,400
TSHA icon
3323
Taysha Gene Therapies
TSHA
$1.13B
$42.9K ﹤0.01%
18,591
+6,350
CYH icon
3324
Community Health Systems
CYH
$452M
$42.7K ﹤0.01%
12,561
-98,048
CCSI icon
3325
Consensus Cloud Solutions
CCSI
$425M
$42.7K ﹤0.01%
1,851
-5,512